A 5-year-old girl from Delhi presents on day 4 of illness with a maculopapular rash that started at the hairline and has spread downward to involve the trunk and upper extremities. She has high fever (39.8°C), severe cough, and mild diarrhea. On examination, the rash is confluent on the face and neck but discrete on the trunk. Her older sibling had a similar illness 10 days ago. What is the most appropriate immediate management?

Explanation

## Management of Measles: Exanthem Phase ### Clinical Diagnosis Confirmation **Key Point:** This patient has **measles in the exanthem (rash) phase**, characterized by: - Maculopapular rash starting at the hairline and spreading downward (cephalocaudal progression) - Confluent rash on face/neck; discrete on trunk (typical distribution pattern) - High fever, severe cough, and systemic symptoms - Contact history (older sibling with similar illness 10 days prior) ### Pathophysiology of Measles Rash The measles rash appears as fever peaks and reflects **immune-mediated response** to viral antigen. It is NOT a direct viral cytopathic effect on skin. ### Management Algorithm for Measles ```mermaid flowchart TD A[Confirmed/Suspected Measles]:::outcome --> B{Severity Assessment}:::decision B -->|Uncomplicated| C[Supportive Care]:::action C --> D[Vitamin A Supplementation]:::action D --> E[Isolation Precautions]:::action B -->|Severe/Immunocompromised| F[Consider IVIG or IM IG]:::action B -->|Complications Present| G[Manage Complications]:::action G --> H[Pneumonia: antibiotics for secondary infection]:::action G --> I[Encephalitis: supportive care, seizure management]:::action E --> J[Monitor for Complications]:::action ``` ### Vitamin A Supplementation: Critical Component **High-Yield:** Vitamin A is **essential** in measles management because: 1. **Reduces morbidity and mortality** by 23–34% in children <5 years 2. **Mechanism:** Restores epithelial integrity, enhances immune response, reduces secondary infections 3. **Dosing (WHO/UNICEF guidelines):** - **Age < 6 months:** 50,000 IU once daily for 2 days - **Age 6 months–1 year:** 100,000 IU once daily for 2 days - **Age > 1 year:** 200,000 IU once daily for 2 days - **Repeat dose after 2 weeks** in high-risk settings (malnutrition, immunodeficiency) **Clinical Pearl:** Vitamin A should be given to ALL children with measles, regardless of nutritional status. It is particularly critical in India where malnutrition is prevalent. ### Supportive Care Measures - **Fluids:** Maintain hydration; oral rehydration for diarrhea - **Nutrition:** Encourage feeding during and after illness - **Fever management:** Paracetamol or ibuprofen as needed - **Cough management:** Honey, steam inhalation; avoid suppressants - **Isolation:** Respiratory isolation for 4 days after rash onset (or until rash fades in immunocompromised) ### Why Antibiotics Are NOT Routine **Warning:** Antibiotics are **NOT indicated** for uncomplicated measles. They are reserved for: - **Secondary bacterial pneumonia** (purulent sputum, focal consolidation on imaging) - **Otitis media with discharge** - **Bacterial superinfection** of skin lesions In this case, the patient has no signs of bacterial superinfection yet; cough is viral prodrome. ### When IVIG Is Indicated IVIG or intramuscular immunoglobulin (IM IG) is reserved for: - **Severely immunocompromised** patients (HIV/AIDS, severe malnutrition, leukemia) - **Post-exposure prophylaxis** within 72 hours in susceptible contacts - **Measles inclusion body encephalitis (MIBE)** in immunocompromised hosts This patient is immunocompetent with uncomplicated measles — IVIG is not indicated. ### Acyclovir: Not Indicated Measles is caused by a **paramyxovirus**, not a herpesvirus. Acyclovir has no role in measles management. **Mnemonic: VISA for Measles Management = Vitamin A, Isolation, Supportive care, Antibiotics (only if secondary infection)** [cite:Park 26e Ch 9; WHO Measles Management Guidelines]